Wall Street Associates’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
CRC
CAM
FLAM
TAM
DCM
KIA
GIM
GP
Wall Street Associates's NEO Position: Q4 2014 in Review
Wall Street Associates sold out of NeoGenomics (NEO) in Q4 2014, closing a stake of 625,000 shares — an estimated $3.26M sold.
Wall Street Associates first reported a position in NEO in Q3 2014 and held it in 1 quarter. The position peaked at $3.26M in Q3 2014. 90 funds tracked by Wall St. Rank hold NEO as of Q4 2014.
- Wall Street Associates reported no remaining NeoGenomics position as of Q4 2014 after selling out during the quarter.
- Wall Street Associates sold 625,000 NeoGenomics shares in Q4 2014, an estimated $3.26M.
- Wall Street Associates first reported a position in NeoGenomics in Q3 2014 and held it in 1 quarter.
- Wall Street Associates's NeoGenomics position peaked at $3.26M in Q3 2014.
- 90 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2014.
Based on Wall Street Associates's 13F filing for Q4 2014, filed 12 Feb 2015.